This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Methotrexate (2013-12-13)
- Starting date:
- December 13, 2013
- Posting date:
- January 3, 2014
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type I
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-37381
Recalled Products
Methotrexate
Reason
Product lots are being recalled due to the potential for cracks in the neck area of the glass container.
Depth of distribution
Wholesale, Retail and Hospital. Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland, Ontario, Quebec, Saskatchewan.
Affected products
Methotrexate
DIN, NPN, DIN-HIM
DIN 02099705Dosage form
Solution for Injection
Strength
25 mg/mL
Lot or serial number
- 12J30KK
- 12J30KH
- 12J30KB
Companies
- Recalling Firm
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
- Marketing Authorization Holder
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA